Ugur Sahin, M.D., Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel ...
FRANKFURT (Reuters) -BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, and the next few weeks will show how urgently an upgrade is needed, ...
Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...
FRANKFURT (Reuters) -BioNTech and Pfizer's COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant, BioNTech's Chief Executive told Reuters, ...
Dr. Ugur Sahin has been vaccinated against COVID-19. The original video in this post is from December 2020, before Sahin was eligible to be vaccinated under Germany’s priority rules. See the sources ...
With the omicron variant fueling new COVID-19 concerns, the CEO of leading vaccine player BioNTech says he's not sure whether a different shot will be needed to protect against the new strain. “This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results